Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy.
Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy. Drug Des Devel Ther. 2019; 13:2565-2577.